Global Radiation Dose Management Market, 2025-2035

Description

List of Tables

Global Radiation Dose Management Market Size, Share & Trends Analysis by Component (Software, and Services), By Modality (Computed Tomography (CT), Fluoroscopy & Interventional Imaging, Radiography & Mammography, and Nuclear Medicine), by Application (Oncology, Cardiology, Orthopedic Applications, and Others) and By End-User (Hospitals, Diagnostic Centers / Imaging Centers, Ambulatory Care Settings, and Others), Forecast Period (2026-2035)

Industry Overview

Radiation dose management market was valued at $442 million in 2025 and is projected to reach $881.3 million by 2035, growing at a CAGR of 6.2% during the forecast Period (2026-2035). The market focuses on solutions that monitor, track, and optimize patient radiation exposure during medical imaging procedures. It includes software and services integrated with modalities such as CT, fluoroscopy, and radiography. Market growth is driven by increasing imaging volumes, regulatory requirements, and rising awareness of patient safety. Technological advancements, including AI-based analytics and cloud platforms, are enhancing system capabilities. The market is expanding across developed and emerging regions with ongoing healthcare digitalization.

Market Dynamics

Rising Adoption of Diagnostic Imaging Procedures

The increasing global use of diagnostic imaging modalities such as CT scans, X-rays, PET, and fluoroscopy is a major driver of the radiation dose management market. With the growing burden of chronic diseases like cancer, cardiovascular, and neurological disorders, the volume of imaging procedures has surged significantly. This has led to higher patient exposure to ionizing radiation, creating a strong need for systems that can monitor, track, and optimize radiation doses. Radiation dose management solutions help healthcare providers ensure safe imaging practices while maintaining diagnostic accuracy, thereby driving their adoption across hospitals and diagnostic centers.

Stringent Regulatory Requirements and Focus on Patient Safety

Governments and international regulatory bodies are increasingly implementing strict guidelines for radiation safety and dose monitoring, which is accelerating market growth. Regulations such as the Euratom Directive in Europe and guidelines from organizations like the IAEA mandate healthcare providers to record, monitor, and optimize radiation exposure for each patient. Additionally, there is a growing emphasis on patient safety and minimizing radiation risks, encouraging healthcare institutions to adopt advanced dose management systems. These solutions help ensure compliance, reduce legal risks, and support accreditation requirements, making them essential in modern healthcare systems.

Technological Advancements and Integration of AI-Based Solutions

Continuous technological advancements, particularly the integration of artificial intelligence (AI) and automation, are significantly driving the radiation dose management market. AI-enabled systems can analyze large volumes of imaging data, provide real-time dose monitoring, and optimize imaging protocols to reduce unnecessary radiation exposure while maintaining image quality. Additionally, innovations such as cloud-based platforms, automated reporting, and interoperability with hospital IT systems (PACS/EHR) enhance efficiency and workflow integration. These advancements not only improve clinical decision-making but also reduce manual workload, making dose management solutions more attractive to healthcare providers.

Market Segmentation

Based on the type, the market is segmented into fine needle biopsy, core needle biopsy, surgical biopsy, and others (lymph node and vacuum-assisted biopsy).
Based on the product, the market is segmented into biopsy needles, guidance systems, biopsy tables, localization wires, assay kits, and others.
Based on the guided technology, the market is segmented into MRI-guided biopsy, ultrasound-guided biopsy, mammography-guided stereotactic biopsy, CT-guided biopsy, and other.
Based on the end-user, the market is segmented into hospitals, diagnostic centers, and research institutes.

Software Segment to Grow at a Considerable Market Share

The software segment is expected to dominate and lead the Global Radiation Dose Management Market as the largest segment by component. This leadership is primarily driven by the critical role software platforms play in capturing, analyzing, and optimizing radiation dose data across multiple imaging modalities and clinical applications. Unlike services, which are periodic or support-based, software solutions are continuously used within healthcare workflows, making them a core revenue-generating component.

Radiation dose management software enables real-time monitoring, automated dose tracking, and comprehensive reporting, which are essential for regulatory compliance and patient safety. Healthcare providers increasingly rely on integrated software systems that seamlessly connect with PACS, RIS, and electronic health records (EHRs), ensuring efficient data management and clinical decision support. Additionally, the growing adoption of AI-powered dose optimization tools further strengthens the demand for advanced software solutions, as they help reduce unnecessary radiation exposure while maintaining image quality.

Moreover, with the rising volume of diagnostic imaging procedures, hospitals and diagnostic centers are prioritizing scalable and cloud-based software platforms that offer centralized dose monitoring across multiple departments and locations. This widespread applicability and continuous utilization position the software segment as the largest and most dominant segment in the global radiation dose management market.

Computed Tomography (CT): A Key Segment in Market Growth

Computed tomography (CT) stands out as the most significant segment driving growth in the global radiation dose management market due to its high radiation exposure levels and widespread clinical utilization. CT scans are extensively used across multiple applications, particularly in oncology and cardiology, for early disease detection, treatment planning, and monitoring. However, compared to other imaging modalities, CT contributes a substantially higher share of cumulative radiation dose to patients, raising concerns about long-term health risks. This has led healthcare providers and regulatory bodies to prioritize dose optimization specifically in CT imaging. Radiation dose management solutions are therefore increasingly integrated with CT systems to monitor patient exposure, standardize imaging protocols, and ensure compliance with safety guidelines. Additionally, the rising global demand for advanced diagnostic imaging, coupled with the growing adoption of multi-slice and high-resolution CT scanners, further amplifies the need for effective dose tracking and management. As a result, CT remains the primary focus area for vendors and healthcare institutions, making it the key segment contributing to the expansion of the radiation dose management market.

Regional Outlook

The global radiation dose management market is further divided by geography, including North America (the US and Canada), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), and the Rest of the World (the Middle East & Africa, and Latin America).

North America Region to Hold a Substantial Growth Rate

In North America, the US dominates the global radiation dose management market, holding a major share due to its advanced healthcare infrastructure, high adoption of diagnostic imaging technologies, and strong regulatory framework. The country performs a significant volume of imaging procedures, particularly CT scans and interventional radiology, which increases the need for effective radiation dose monitoring solutions. Regulatory bodies such as the US Food and Drug Administration (FDA) and initiatives like the Image Wisely and Image Gently campaigns have reinforced the importance of minimizing radiation exposure, encouraging widespread adoption of dose management systems across hospitals and diagnostic centers. Additionally, the presence of leading market players, continuous technological advancements, and early integration of AI-driven healthcare solutions further support market growth in the US. High healthcare expenditure and strong awareness regarding patient safety also contribute to the country's leadership position. Furthermore, the increasing focus on value-based care and quality assurance compels healthcare providers to implement robust radiation monitoring systems to enhance clinical outcomes and maintain compliance. As a result, the United States continues to lead the global radiation dose management market, setting benchmarks in both technology adoption and patient safety standards.

Market Players Outlook

The major companies operating in the global radiation dose management market include Bayer AG, Fujifilm Holdings Corp., GE HealthCare, Koninklijke Philips N.V., Siemens Healthineers, among others. Market players are leveraging partnerships, collaborations, mergers, and acquisitions to expand their businesses and develop innovative products to maintain their market positioning.

Recent Development

In December 2025, Virtual Phantoms Inc. launched VirtualDose DX, a next-generation radiation dose management and simulation software designed to provide patient-specific dose estimation. The solution allows healthcare providers to adjust imaging parameters and standardize radiation exposure across procedures, improving accuracy, regulatory compliance, and patient safety in diagnostic imaging.
In June 2025, iQ IMAGE launched iQ-DOSE 2.0, an upgraded radiation dose management solution aimed at enhancing visual clarity and user experience. This version supports medical physicists and radiologists in managing patient radiation exposure through improved documentation, evaluation, and optimization, along with new features that enhance usability, data visualization, and workflow efficiency.
In April 2024, Mirion Technologies introduced Instadose VUE, a next-generation personal electronic dosimeter that enables real-time radiation exposure monitoring. The device features wireless data transmission, instant dose display, and automated alerts when exposure limits are exceeded, enhancing safety for healthcare professionals and supporting advanced dose management practices.

The Report Covers:

Market value data analysis for 2025 and forecast to 2035.
Annualized market revenues ($ million) for each market segment.
Country-wise analysis of major geographical regions.
Key companies operating in the global radiation dose management market. Based on the availability of data, information related to new products and relevant news is also available in the report.
Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
Analysis of market-entry and market expansion strategies.
Competitive strategies by identifying 'who-stands-where' in the market.

Product Code: OMR2026547

1. Report Summary

Current Industry Analysis and Growth Potential Outlook
Global Radiation Dose Management Market Sales Analysis - Component | Modality | Application| End-User ($ Million)
Radiation Dose Management Market Sales Performance of Top Countries
1.1. Research Methodology
Primary Research Approach
Secondary Research Approach
1.2. Market Snapshot

2. Market Overview and Insights

2.1. Scope of the Study
2.2. Analyst Insight & Current Market Trends
- 2.2.1. Key Radiation Dose Management Market Trends
- 2.2.2. Market Recommendations
2.3. Porter's Five Forces Analysis for the Radiation Dose Management Market
- 2.3.1. Competitive Rivalry
- 2.3.2. Threat of New Entrants
- 2.3.3. Bargaining Power of Suppliers
- 2.3.4. Bargaining Power of Buyers
- 2.3.5. Threat of Substitutes

3. Market Determinants

3.1. Market Drivers
- 3.1.1. Drivers For Global Radiation Dose Management Market: Impact Analysis
3.2. Market Pain Points and Challenges
- 3.2.1. Restraints For Global Radiation Dose Management Market: Impact Analysis
3.3. Market Opportunities
- 3.3.1. Opportunities For Global Radiation Dose Management Market: Impact Analysis

4. Competitive Landscape

4.1. Competitive Dashboard - Radiation Dose Management Market Revenue and Share by Manufacturers
Radiation Dose Management Modality Comparison Analysis
Top Market Player Ranking Matrix
4.2. Key Company Analysis
- 4.2.1. Bayer AG
  - 4.2.1.1. Overview
  - 4.2.1.2. Modality Portfolio
  - 4.2.1.3. Financial Analysis
  - 4.2.1.4. SWOT Analysis
  - 4.2.1.5. Business Strategy
- 4.2.2. Fujifilm Holdings Corp.
  - 4.2.2.1. Overview
  - 4.2.2.2. Modality Portfolio
  - 4.2.2.3. Financial Analysis
  - 4.2.2.4. SWOT Analysis
  - 4.2.2.5. Business Strategy
- 4.2.3. GE HealthCare
  - 4.2.3.1. Overview
  - 4.2.3.2. Modality Portfolio
  - 4.2.3.3. Financial Analysis
  - 4.2.3.4. SWOT Analysis
  - 4.2.3.5. Business Strategy
- 4.2.4. Koninklijke Philips N.V.
  - 4.2.4.1. Overview
  - 4.2.4.2. Modality Portfolio
  - 4.2.4.3. Financial Analysis
  - 4.2.4.4. SWOT Analysis
  - 4.2.4.5. Business Strategy
- 4.2.5. Siemens Healthineers
  - 4.2.5.1. Overview
  - 4.2.5.2. Modality Portfolio
  - 4.2.5.3. Financial Analysis
  - 4.2.5.4. SWOT Analysis
  - 4.2.5.5. Business Strategy
4.3. Top Winning Strategies by Market Players
- 4.3.1. Merger and Acquisition
- 4.3.2. Modality Launch
- 4.3.3. Partnership And Collaboration

5. Global Radiation Dose Management Market Sales Analysis by Component ($ Million)

5.1. Software
5.2. Services

6. Global Radiation Dose Management Market Sales Analysis by Modality ($ Million)

6.1. Computed Tomography (CT)
6.2. Fluoroscopy & Interventional Imaging
6.3. Radiography & Mammography
6.4. Nuclear Medicine

7. Global Radiation Dose Management Market Sales Analysis by Application ($ Million)

7.1. Oncology
7.2. Cardiology
7.3. Orthopedic Applications
7.4. Others

8. Global Radiation Dose Management Market Sales Analysis by End-User ($ Million)

8.1. Hospitals
8.2. Diagnostic Centres / Imaging Centres
8.3. Ambulatory Care Settings
8.4. Others

9. Regional Analysis

9.1. North American Radiation Dose Management Market Sales Analysis - Component | Modality | Application | End-User | Country ($ Million)
Macroeconomic Factors for North America
- 9.1.1. United States
- 9.1.2. Canada
9.2. European Radiation Dose Management Market Sales Analysis - Component | Modality | Application | End-User | Country ($ Million)
Macroeconomic Factors for Europe
- 9.2.1. UK
- 9.2.2. Germany
- 9.2.3. Italy
- 9.2.4. Spain
- 9.2.5. France
- 9.2.6. Russia
- 9.2.7. Rest of Europe
9.3. Asia-Pacific Radiation Dose Management Market Sales Analysis - Component | Modality | Application | End-User | Country ($ Million)
Macroeconomic Factors for Asia-Pacific
- 9.3.1. China
- 9.3.2. Japan
- 9.3.3. South Korea
- 9.3.4. India
- 9.3.5. Australia & New Zealand
- 9.3.6. ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Other)
- 9.3.7. Rest of Asia-Pacific
9.4. Rest of the World Radiation Dose Management Market Sales Analysis - Component | Modality | Application | End-User | Country ($ Million)
Macroeconomic Factors for the Rest of the World
- 9.4.1. Latin America
- 9.4.2. Middle East and Africa

10. Company Profiles

10.1. Agfa-Gevaert Group
- 10.1.1. Quick Facts
- 10.1.2. Company Overview
- 10.1.3. Product Portfolio
- 10.1.4. Business Strategies
10.2. Bayer AG
- 10.2.1. Quick Facts
- 10.2.2. Company Overview
- 10.2.3. Product Portfolio
- 10.2.4. Business Strategies
10.3. Bracco Imaging S.p.A.
- 10.3.1. Quick Facts
- 10.3.2. Company Overview
- 10.3.3. Product Portfolio
- 10.3.4. Business Strategies
10.4. Canon Inc.
- 10.4.1. Quick Facts
- 10.4.2. Company Overview
- 10.4.3. Product Portfolio
- 10.4.4. Business Strategies
10.5. Fujifilm Holdings Corp.
- 10.5.1. Quick Facts
- 10.5.2. Company Overview
- 10.5.3. Product Portfolio
- 10.5.4. Business Strategies
10.6. GE HealthCare
- 10.6.1. Quick Facts
- 10.6.2. Company Overview
- 10.6.3. Product Portfolio
- 10.6.4. Business Strategies
10.7. Guerbet
- 10.7.1. Quick Facts
- 10.7.2. Company Overview
- 10.7.3. Product Portfolio
- 10.7.4. Business Strategies
10.8. Imalogix
- 10.8.1. Quick Facts
- 10.8.2. Company Overview
- 10.8.3. Product Portfolio
- 10.8.4. Business Strategies
10.9. Infinitt Healthcare Co., Ltd.
- 10.9.1. Quick Facts
- 10.9.2. Company Overview
- 10.9.3. Product Portfolio
- 10.9.4. Business Strategies
10.10. Koninklijke Philips N.V.
- 10.10.1. Quick Facts
- 10.10.2. Company Overview
- 10.10.3. Product Portfolio
- 10.10.4. Business Strategies
10.11. Medic Vision Imaging Solutions Ltd.
- 10.11.1. Quick Facts
- 10.11.2. Company Overview
- 10.11.3. Product Portfolio
- 10.11.4. Business Strategies
10.12. Medsquare
- 10.12.1. Quick Facts
- 10.12.2. Company Overview
- 10.12.3. Product Portfolio
- 10.12.4. Business Strategies
10.13. Mirion Technologies, Inc.
- 10.13.1. Quick Facts
- 10.13.2. Company Overview
- 10.13.3. Product Portfolio
- 10.13.4. Business Strategies
10.14. Novarad Corp.
- 10.14.1. Quick Facts
- 10.14.2. Company Overview
- 10.14.3. Product Portfolio
- 10.14.4. Business Strategies
10.15. PACSHealth, LLC
- 10.15.1. Quick Facts
- 10.15.2. Company Overview
- 10.15.3. Product Portfolio
- 10.15.4. Business Strategies
10.16. Qaelum N.V.
- 10.16.1. Quick Facts
- 10.16.2. Company Overview
- 10.16.3. Product Portfolio
- 10.16.4. Business Strategies
10.17. Sectra AB
- 10.17.1. Quick Facts
- 10.17.2. Company Overview
- 10.17.3. Product Portfolio
- 10.17.4. Business Strategies
10.18. Siemens Healthineers AG
- 10.18.1. Quick Facts
- 10.18.2. Company Overview
- 10.18.3. Product Portfolio
- 10.18.4. Business Strategies
10.19. Thermo Fisher Scientific Inc.
- 10.19.1. Quick Facts
- 10.19.2. Company Overview
- 10.19.3. Product Portfolio
- 10.19.4. Business Strategies
10.20. Volpara Health Ltd.
- 10.20.1. Quick Facts
- 10.20.2. Company Overview
- 10.20.3. Product Portfolio
- 10.20.4. Business Strategies